Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis

Ovarian Stimulation ◽

Meta Analysis ◽

Reproductive Technology ◽

PBI1 Comparison of the Combination of Recombinant Follicle-Stimulating Hormone and Recombinant Luteinizing Hormone Protocol Versus Human Menopausal Gonadotropin Protocol in Controlled Ovarian Stimulation: A Systematic Review and Meta-Analysis

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.009 ◽

2020 ◽

Vol 22 ◽

pp. S2

Author(s):

Y. Wang ◽

L. Li ◽

K. Deng ◽

J. Liu ◽

Y. Liu ◽

...

Keyword(s):

Systematic Review ◽

Luteinizing Hormone ◽

Ovarian Stimulation ◽

Meta Analysis ◽

Controlled Ovarian Stimulation ◽

Comparison of the combination of recombinant follicle‐stimulating hormone and recombinant luteinizing hormone protocol versus human menopausal gonadotropin protocol in controlled ovarian stimulation: A systematic review and meta‐analysis

Journal of Evidence-Based Medicine ◽

10.1111/jebm.12390 ◽

2020 ◽

Vol 13 (3) ◽

pp. 215-226

Author(s):

Yuning Wang ◽

Ling Li ◽

Ke Deng ◽

Jiali Liu ◽

Yanmei Liu ◽

...

Keyword(s):

Systematic Review ◽

Luteinizing Hormone ◽

Ovarian Stimulation ◽

Meta Analysis ◽

Controlled Ovarian Stimulation ◽

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis

Frontiers in Endocrinology ◽

10.3389/fendo.2017.00264 ◽

2017 ◽

Vol 8 ◽

Cited By ~ 2

Author(s):

Johnny S. Younis

Keyword(s):

Luteinizing Hormone ◽

Personalized Medicine ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Meta Analysis ◽

Reproductive Technology ◽

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis

Frontiers in Endocrinology ◽

10.3389/fendo.2018.00113 ◽

2018 ◽

Vol 9 ◽

Cited By ~ 2

Author(s):

Daniele Santi ◽

Livio Casarini ◽

Carlo Alviggi ◽

Manuela Simoni

Keyword(s):

Luteinizing Hormone ◽

Personalized Medicine ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Meta Analysis ◽

Reproductive Technology ◽

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis

Frontiers in Endocrinology ◽

10.3389/fendo.2017.00114 ◽

2017 ◽

Vol 8 ◽

Cited By ~ 36

Author(s):

Daniele Santi ◽

Livio Casarini ◽

Carlo Alviggi ◽

Manuela Simoni

Keyword(s):

Luteinizing Hormone ◽

Personalized Medicine ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Meta Analysis ◽

Reproductive Technology ◽

RECOMBINANT LUTEINIZING HORMONE ASSOCIATED WITH RECOMBINANT FOLLICLE STIMULATING HORMONE FOR OVARIAN STIMULATION: DECREASED INCIDENCE OF IMMATURE OOCYTES AND BETTER CLINICAL OUTCOMES

Fertility and Sterility ◽

10.1016/j.fertnstert.2020.08.1325 ◽

2020 ◽

Vol 114 (3) ◽

pp. e459

Author(s):

Edson Borges ◽

Daniela Paes de Almeida Ferreira Braga ◽

Amanda Souza Setti ◽

Assumpto Iaconelli

Keyword(s):

Luteinizing Hormone ◽

Clinical Outcomes ◽

Ovarian Stimulation ◽

Immature Oocytes ◽

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review

Fertility and Sterility ◽

10.1016/j.fertnstert.2018.01.003 ◽

2018 ◽

Vol 109 (4) ◽

pp. 644-664 ◽

Cited By ~ 33

Author(s):

Carlo Alviggi ◽

Alessandro Conforti ◽

Sandro C. Esteves ◽

Claus Yding Andersen ◽

Ernesto Bosch ◽

...

Keyword(s):

Systematic Review ◽

Luteinizing Hormone ◽

Reproductive Technology ◽

Recombinant Luteinizing Hormone

Re: Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis. T. N. Bechtejew, M. N. Nadai, C. O. Nastri and W. P. Martins. Ultrasound Obstet Gynecol 2017; 50: 315-

Ultrasound in Obstetrics and Gynecology ◽

10.1002/uog.18822 ◽

2017 ◽

Vol 50 (3) ◽

pp. 294-294

Author(s):

C. Siristatidis

Keyword(s):

Systematic Review ◽

Ovarian Stimulation ◽

Obstet Gynecol ◽

Meta Analysis ◽

Clomiphene Citrate ◽

Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle- stimulating hormone

Fertility and Sterility ◽

10.1016/s0015-0282(00)01745-3 ◽

2001 ◽

Vol 75 (3) ◽

pp. 519-524 ◽

Cited By ~ 59

Author(s):

Melissa A Esposito ◽

Kurt T Barnhart ◽

Christos Coutifaris ◽

Pasquale Patrizio

Keyword(s):

Luteinizing Hormone ◽

Reproductive Technology ◽

Technology Cycles ◽

Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged >=35 years: a randomized controlled trial

Human Reproduction ◽

10.1093/humrep/dev038 ◽

2015 ◽

Vol 30 (5) ◽

pp. 1188-1195 ◽

Cited By ~ 17

Author(s):

T. N. L. Vuong ◽

H. T. Phung ◽

M. T. Ho

Keyword(s):

Randomized Controlled Trial ◽

Luteinizing Hormone ◽

Ovarian Stimulation ◽

Gnrh Antagonist ◽

Controlled Trial ◽

Randomized Controlled ◽